Lonza

General information
Lonza
Muenchensteinerstrasse 38
4002 Basel, Basle-City (BS)
Switzerland

Contact person: Max Bayer, Project Manager
Company main phone: +41 (61) 3168111
Company main fax:  +41 (61) 3169111
Website:  http://www.lonza.com
Year founded:1897
Source of foundation:Subsidiary
Name of foundation source:Lonza Group
Corporate description / mission:
Lonza focuses on the formulation and drug product process development, drug product analytical development, and quality control. Specialized services are available for particulate identification, characterization and quantification, excipient and surfactant characterization, extractable and leachable assessment, product comparability, and testing of container closure integrity and drug/device combination products.
State of ownership: Subsidiary
Headquarters: No
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Analytical services
  • CMO (Contract Manufacturing Organization)
  • Fill & finish
Primary therapeutic areas:
  • Cardiovascular / cardiology
  • Digestive system / gastroenterology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Mental and behavioural disorders / psychiatry /psychology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Pregnancy, childbirth and the puerperium / obstetrics
  • Respiratory / pulmonology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • Manufacturer
  • R&D
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Distribution:
  • Direct (own sales force)
X